ng-nitroarginine methyl ester has been researched along with Kidney Diseases in 73 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (16.44) | 18.2507 |
| 2000's | 40 (54.79) | 29.6817 |
| 2010's | 20 (27.40) | 24.3611 |
| 2020's | 1 (1.37) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelhady, SA; Darwish, IE; El-Deeb, NM; El-Mas, MM; Gowayed, MA; Habib, YH | 1 |
| Cuello-Carrión, FD; Docherty, N; Manucha, W; Mazzei, L | 1 |
| El-Ashmony, SM; Fatani, SH; Kamel, HF; Shamardl, HA | 1 |
| Abdel Kawy, HS | 1 |
| Abd-Eldayem, AM; Abdel-Zaher, AO; El-Refaiy, AEM; Farghaly, HSM | 1 |
| Chen, JR; Huang, WC; Ko, J; Yang, HY; Yeh, WJ | 1 |
| Abdel-Latif, RG; El-Sheikh, AAK; Morsy, MA | 1 |
| Azarbayjani, MA; Habibian, M; Hedayati, M; Peeri, M | 1 |
| Arévalo, M; Blanca, AJ; Mate, A; Miguel-Carrasco, JL; Ruiz-Armenta, MV; Vázquez, CM; Zambrano, S | 1 |
| Alp Yildirim, FI; Balci Ekmekçi, Ö; Demirci Tansel, C; Eker Kizilay, D; Ergin, B; Kucur, M; Topal, G; Uydeş Doğan, BS | 1 |
| Barbaro, NR; Bernstein, KE; Chen, W; Dale, BL; Foss, JD; Harrison, DG; Itani, HA; Kirabo, A; Madhur, MS; Mallal, SA; Montaniel, KR; Navar, LG; Norlander, AE; Pilkinton, MA; Saleh, MA; Sato, R; Wu, J; Xiao, L | 1 |
| Grande, JP; Juncos, LA; LaMarca, BD; Lopez-Ruiz, A; Moulana, M; Patil, CN; Reckelhoff, JF; Soljancic, A; Wallace, K | 1 |
| Choi, EK; Jee, DL; Jung, H; Kim, S; Kwak, KH; Lim, DG; Lim, JA; Park, JM; Park, SH; Yi, SJ | 1 |
| Ishizawa, K; Izawa, Y; Kagami, S; Kanematsu, Y; Kawazoe, K; Kondo, S; Motobayashi, Y; Ohnishi, H; Tamaki, T; Tomita, S; Tsuchiya, K; Yamaguchi, K | 1 |
| Hayashida, H; Hirakata, H; Iida, M; Ikeda, H; Masutani, K; Toyonaga, J; Tsuruya, K | 1 |
| Brem, AS | 1 |
| Chadjichristos, C; Chatziantoniou, C; Dussaule, JC; Flamant, M; François, H; Guerrot, D; Helle, F; Jouzel, C; Placier, S | 1 |
| Abe, S; Ikeda, Y; Ishizawa, K; Kihira, Y; Tamaki, T; Tomita, S; Tsuchiya, K | 1 |
| Chatziantoniou, C; Helle, F; Iversen, BM | 1 |
| Carlström, M; Fredholm, BB; Kouzmine, M; Olerud, J; Persson, AE; Sällström, J; Sandler, S | 1 |
| Farias, RE; Ferreira, AP; Girardi, JM; Raposo, NR | 1 |
| Bidani, A; Griffin, K; Licea-Vargas, H; Long, J; Picken, M; Polichnowski, A; Williamson, G | 1 |
| Azegami, T; Hayashi, K; Itoh, H; Sasamura, H | 1 |
| Chatziantoniou, C; Dussaule, JC; Guerrot, D; Mael-Ainin, M; Placier, S; Rondeau, E; Xu-Dubois, YC | 1 |
| Bachhav, SS; Baser, B; Bhutada, MS; Chaudhari, KB; Patil, SD | 1 |
| Del Moral, R; O'Valle, F; Osuna, A; Vargas, F; Wangensteen, R | 1 |
| Hasuike, Y; Hiraoka, K; Inoue, T; Itahana, R; Izumi, M; Miyagawa, K; Nakanishi, T; Nishihara, F; Takamitsu, Y | 1 |
| Andoh, TF; Bennett, WM; Isaac, J; Shihab, FS; Yi, H | 1 |
| Goldfarb, M; Heyman, SN; Karmeli, F; Rosen, S; Shina, A | 1 |
| Maines, MD; Mayer, RD; Wang, X | 1 |
| Al-Shabanah, OA; El-Khashef, HA; Mansour, MA | 1 |
| Alkan, Z; Bilgen, I; Cirrik, S; Edremitlioğlu, M; Oner, G | 1 |
| Adler, GK; Jonasson, L; Martinez-Vasquez, D; Mukasa, K; Oestreicher, EM; Roubsanthisuk, W; Stone, JR | 1 |
| Brond, L; Christensen, S; Graebe, M; Jonassen, TE; Nielsen, S; Olsen, NV | 1 |
| Chansel, D; Chatziantoniou, C; Dussaule, JC; Flamant, M; François, H; Placier, S; Tharaux, PL | 1 |
| Casarini, DE; Cavaglieri, Rde C; Dellê, H; Dominguez, WV; Graciano, ML; Malheiros, DM; Noronha, IL | 1 |
| Arslan, A; Büyükbayram, H; Kara, IH; Oztürk, H | 1 |
| Gol, A; Kadkhodaee, M | 1 |
| Davis, NA; Inman, SR; Lukaszek, VA; Mazzone, ME; Olson, KM; Yoder, KN | 1 |
| Chander, V; Chopra, K | 2 |
| Frohlich, ED; Matavelli, LC; Ono, H; Zhou, X | 1 |
| Jacob, HJ; Lazar, J; Provoost, AP; Specht, PA; Van Dijk, SJ | 2 |
| El-Demerdash, E; Saleh, S | 1 |
| Bay, A; Eşrefoğlu, M; Kuruş, M; Oztürk, F | 1 |
| Baylis, C; Erdely, A; Freshour, G | 1 |
| Alfaro, V; Genescà, M; Hotter, G; Pí, F; Sola, A; Viñas, JL | 1 |
| Demova, H; Kluckova, H; Komers, R; Lecian, D; Lodererova, A; Teplan, V; Voska, L; Zdychova, J | 1 |
| Ghaznavi, R; Kadkhodaee, M | 1 |
| Frohlich, ED; Zhou, X | 1 |
| Chander, V; Chopra, K; Gupta, A; Sharma, S | 1 |
| Chen, H; Chen, Z; Liu, X; Xing, B; Zhan, B; Zhou, J; Zhu, H | 1 |
| Dechend, R; Dietz, R; Gross, V; Henke, N; Luft, FC; Muller, DN; Obst, M; Park, JK; Qadri, F; Scheidereit, C; Schmidt-Ullrich, R; Wellner, M | 1 |
| Cowley, AW; Dwinell, MR; Greene, AS; Jacob, HJ; Kwitek, AE; Mattson, DL; Roman, RJ | 1 |
| Manucha, W; Vallés, PG | 1 |
| Inoue, T; Iwai, J; Kanayama, Y; Konishi, Y; Negoro, N; Nishimura, M; Okamura, M; Takeda, T; Umetani, N | 1 |
| Raij, L; Shultz, PJ; Westberg, G | 1 |
| Alvarado, JA; Bobadilla, NA; Franco, M; García-Torres, R; Herrera-Acosta, J; López, P; Mendoza, S; Tapia, E | 1 |
| Arévalo, M; López-Novoa, JM; Rivas-Cabañero, L; Rodriguez-Barbero, A | 1 |
| De Nucci, G; Fujihara, CK; Malheiros, DM; Sassaki, AL; Yamada, SS; Zatz, R | 1 |
| Andoh, TF; Bennett, WM; Gardner, MP; Houghton, DC; Lindsley, J | 1 |
| Imaizumi, T; Kohno, K; Matsuoka, H; Morimatsu, M; Nakashima, A; Nishida, H; Nomura, G; Yasukawa, H | 1 |
| Blot, S; Chatellier, G; Michel, JB; Philippe, M; Xu, Y | 1 |
| Ishidoya, S; Klahr, S; McCracken, R; Morrissey, JJ | 1 |
| Jacob, HJ; Provoost, AP; van Dokkum, RP | 1 |
| Andoh, TF; Bennett, WM; Gardner, MP | 1 |
| Cohen, EP; Fish, BL; Moulder, JE | 1 |
| Fujishima, M; Goto, H; Hirakata, H; Hirano, T; Kashiwagi, M; Okuda, S; Shinozaki, M; Tamaki, K; Tokumoto, M | 1 |
| Andoh, TF; Bennett, WM; Shihab, FS; Yi, H | 1 |
| Kubodera, S; Takeda, M; Ueno, A; Wang, L | 1 |
| Chen, KM; Jia, YF; Morcos, SK; Wang, YX | 1 |
| Jover, B; Mimran, A | 1 |
3 review(s) available for ng-nitroarginine methyl ester and Kidney Diseases
| Article | Year |
|---|---|
Dietary nitrite ameliorates renal injury in L-NAME-induced hypertensive rats.
Topics: Animals; Diet; Hypertension; Kidney Diseases; NG-Nitroarginine Methyl Ester; Rats; Sodium Nitrite | 2010 |
Analogy of cardiac and renal complications in essential hypertension and aged SHR or L-NAME/SHR.
Topics: Aging; Animals; Antihypertensive Agents; Disease Models, Animal; Enzyme Inhibitors; Heart Diseases; Hypertension; Kidney Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR | 2007 |
Nitric oxide inhibition and renal alterations.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Chronic Disease; Disease Models, Animal; Enzyme Inhibitors; Humans; Kidney; Kidney Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Receptors, Angiotensin; Renin-Angiotensin System | 2001 |
70 other study(ies) available for ng-nitroarginine methyl ester and Kidney Diseases
| Article | Year |
|---|---|
Modulation by antenatal therapies of cardiovascular and renal programming in male and female offspring of preeclamptic rats.
Topics: Animals; Atrasentan; Cardiovascular Diseases; Disease Models, Animal; Endothelin A Receptor Antagonists; Female; Kidney Diseases; Male; Methyldopa; Naphthalenes; NG-Nitroarginine Methyl Ester; Pre-Eclampsia; Pregnancy; Prenatal Care; Propionates; Rats; Receptors, Thromboxane A2, Prostaglandin H2; Sex Factors; Sympatholytics | 2021 |
Heat shock protein 70/nitric oxide effect on stretched tubular epithelial cells linked to WT-1 cytoprotection during neonatal obstructive nephropathy.
Topics: Animals; Apoptosis; Arginine; Cells, Cultured; Cytoprotection; Epithelial Cells; Fibrosis; Gene Expression; HSP70 Heat-Shock Proteins; Kidney Cortex; Kidney Diseases; Kidney Tubules; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Rats; Rats, Inbred WKY; Stress, Mechanical; Ureteral Obstruction; WT1 Proteins | 2017 |
Potential Cardiovascular and Renal Protective Effects of Vitamin D and Coenzyme Q
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cardiovascular Diseases; Hypertension; Kidney Diseases; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Ubiquinone; Valsartan; Vitamin D; Vitamins | 2017 |
Aliskiren and valsartan in combination is a promising therapy for hypertensive renal injury in rats.
Topics: Amides; Animals; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Creatinine; Drug Therapy, Combination; Enzyme Inhibitors; Fumarates; Hypertension; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Oxidative Stress; Proteinuria; Rats; Rats, Wistar; Valsartan | 2018 |
Protective effect of the standardized leaf extract of Ginkgo biloba (EGb761) against hypertension-induced renal injury in rats.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Cardiovascular Agents; Ginkgo biloba; Glutathione; Hypertension; Hypertension, Renal; Interleukin-1beta; Interleukin-6; Kidney; Kidney Diseases; Losartan; Male; Malondialdehyde; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Plant Extracts; Rats; Tumor Necrosis Factor-alpha | 2018 |
Renoprotective Effects of Antroquinonol in Rats with N
Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Antioxidants; Antrodia; Arginine; Arterioles; Biological Products; Biomarkers; Blood Pressure; Disease Models, Animal; Hypertension; Inflammation; Kidney; Kidney Diseases; Male; Malondialdehyde; NG-Nitroarginine Methyl Ester; Oxidative Stress; Rats, Wistar; Ubiquinone | 2018 |
Modulation of eNOS/iNOS by nebivolol protects against cyclosporine A-mediated nephrotoxicity through targeting inflammatory and apoptotic pathways.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Apoptosis; Cyclosporine; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Nebivolol; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protective Agents; Rats, Wistar | 2019 |
Protective effect of aerobic exercise against L-NAME-induced kidney damage in rats.
Topics: Animals; Cytoprotection; Down-Regulation; HSP70 Heat-Shock Proteins; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Motor Activity; NG-Nitroarginine Methyl Ester; Nitrates; Oxidative Stress; Physical Conditioning, Animal; Random Allocation; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2013 |
L-carnitine attenuates the development of kidney fibrosis in hypertensive rats by upregulating PPAR-γ.
Topics: Animals; Carnitine; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Cytoprotection; Disease Models, Animal; Enzyme Inhibitors; Fibrosis; Hypertension; Inflammation Mediators; Interleukin-10; Interleukin-1beta; Interleukin-6; Kidney Diseases; Kidney Tubules, Proximal; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; NG-Nitroarginine Methyl Ester; PPAR gamma; Rats; Rats, Wistar; Transforming Growth Factor beta1; Up-Regulation | 2014 |
Barnidipine ameliorates the vascular and renal injury in L-NAME-induced hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Inflammation Mediators; Kidney; Kidney Diseases; Male; Malondialdehyde; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxidase; Rats, Wistar; Renal Artery; Time Factors; Vascular Remodeling; Vasoconstriction; Vasodilation | 2015 |
CD70 Exacerbates Blood Pressure Elevation and Renal Damage in Response to Repeated Hypertensive Stimuli.
Topics: Animals; Blood Pressure; CD27 Ligand; Hypertension; Inflammation Mediators; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Sodium Chloride, Dietary; T-Lymphocytes | 2016 |
Low-dose testosterone protects against renal ischemia-reperfusion injury by increasing renal IL-10-to-TNF-α ratio and attenuating T-cell infiltration.
Topics: Animals; Creatine; Cytokines; Enzyme Inhibitors; Interleukin-10; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitrites; Rats; Rats, Sprague-Dawley; Reperfusion Injury; T-Lymphocytes; Testosterone; Th17 Cells; Tumor Necrosis Factor-alpha | 2016 |
Inhibition of Oxidative Stress in Renal Ischemia-Reperfusion Injury.
Topics: Allopurinol; Animals; Antioxidants; Apoptosis; Blood Urea Nitrogen; Creatinine; Cytoprotection; Disease Models, Animal; Enzyme Inhibitors; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Metalloporphyrins; Monocytes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Peroxynitrous Acid; Rats, Sprague-Dawley; Reperfusion Injury; Superoxides; Xanthine Oxidase | 2017 |
Dietary doses of nitrite restore circulating nitric oxide level and improve renal injury in L-NAME-induced hypertensive rats.
Topics: Administration, Oral; Animals; Blood Pressure; Body Weight; Diet; Glycated Hemoglobin; Hypertension; Kidney; Kidney Diseases; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Proteinuria; Rats; Rats, Sprague-Dawley | 2008 |
Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats.
Topics: Animals; Fibrosis; Hemodynamics; Inflammation; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Osteopontin; Protective Agents; Rats; Rats, Wistar; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone | 2009 |
The Janus effect: two faces of aldosterone.
Topics: Adrenal Cortex Hormones; Aldosterone; Animals; Humans; Kidney Diseases; NG-Nitroarginine Methyl Ester; Rats; Sodium; Spironolactone | 2009 |
Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.
Topics: Animals; Arterioles; Blood Pressure; Chronic Disease; Disease Models, Animal; Enzyme Inhibitors; ErbB Receptors; Gefitinib; Hypertension; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Quinazolines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasoconstriction | 2009 |
Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Disease Models, Animal; Endothelins; Endothelium, Vascular; Enzyme Inhibitors; Hydralazine; Kidney; Kidney Diseases; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Vasoconstriction | 2010 |
High-protein-induced glomerular hyperfiltration is independent of the tubuloglomerular feedback mechanism and nitric oxide synthases.
Topics: Animals; Dietary Proteins; Disease Models, Animal; Enzyme Inhibitors; Feedback, Physiological; Female; Glomerular Filtration Rate; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Receptor, Adenosine A1; Time Factors | 2010 |
Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide-deficient rats.
Topics: Animals; Blood Pressure; Drug Therapy, Combination; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Interleukins; Kidney Diseases; Male; Nephritis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plethysmography; Proteinuria; Pyrimidines; Random Allocation; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides | 2011 |
Large BP-dependent and -independent differences in susceptibility to nephropathy after nitric oxide inhibition in Sprague-Dawley rats from two major suppliers.
Topics: Animals; Blood Pressure; Hypertension; Kidney Diseases; Kidney Glomerulus; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Proteinuria; Rats; Rats, Sprague-Dawley; Vasoconstriction | 2012 |
Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Enzyme Inhibitors; Hydralazine; Kidney Diseases; Kidney Glomerulus; Male; Membrane Proteins; NG-Nitroarginine Methyl Ester; Proteinuria; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Tetrazoles; Vaccines | 2012 |
Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy.
Topics: Animals; Biomarkers; Blood Pressure; Cell Adhesion Molecules; Disease Progression; Gene Expression Regulation; Humans; Hypertension; Kidney Diseases; Kidney Transplantation; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Transplantation, Homologous; Vascular Diseases | 2012 |
Effect of Viscum articulatum Burm. (Loranthaceae) in Nω-nitro-L-arginine methyl ester induced hypertension and renal dysfunction.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cholesterol; Creatinine; Drugs, Chinese Herbal; Enalapril; Hypertension; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phytotherapy; Potassium; Rats; Rats, Wistar; Renal Agents; Urination; Viscum | 2012 |
Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Desoxycorticosterone; Disease Models, Animal; Enzyme Inhibitors; Hypertension, Renal; Kidney; Kidney Diseases; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Renin; Time Factors | 2002 |
A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol.
Topics: Adrenergic beta-Antagonists; Animals; Cyclic GMP; Enzyme Inhibitors; Hypertension; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrites; Propanolamines; Propranolol; Proteinuria; Rats; Rats, Inbred F344; Renin | 2003 |
Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity.
Topics: Animals; Chronic Disease; Cyclosporine; Enzyme Inhibitors; Extracellular Matrix Proteins; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2003 |
N-acetylcysteine ameliorates renal microcirculation: studies in rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Dinoprostone; Enzyme Inhibitors; Hypoxia; Kidney Cortex; Kidney Diseases; Kidney Medulla; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Circulation | 2003 |
Nitric oxide inhibitor N omega -nitro-l-arginine methyl ester potentiates induction of heme oxygenase-1 in kidney ischemia/reperfusion model: a novel mechanism for regulation of the oxygenase.
Topics: Animals; Enzyme Induction; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxygenases; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger | 2003 |
L-arginine ameliorates kidney function and urinary bladder sensitivity in experimentally-induced renal dysfunction in rats.
Topics: Acetylcholine; Animals; Antineoplastic Agents; Arginine; Catalase; Cisplatin; Creatinine; Glutathione; Glutathione Peroxidase; Kidney; Kidney Diseases; Kidney Function Tests; Lipid Peroxides; Male; NG-Nitroarginine Methyl Ester; Rats; Urea; Urinary Bladder | 2003 |
Involvement of cholinoceptors in cadmium-induced endothelial dysfunction.
Topics: Acetylcholine; Administration, Oral; Animals; Aorta, Thoracic; Atropine; Cadmium; Calcimycin; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Gallamine Triethiodide; Glomerular Filtration Rate; Hypertension; Indomethacin; Kidney Cortex; Kidney Diseases; Male; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitroprusside; Peripheral Vascular Diseases; Phenylephrine; Pirenzepine; Prostaglandins; Rats; Rats, Wistar; Receptor, Muscarinic M1; Vasodilation | 2003 |
Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Coronary Artery Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Myocardium; NG-Nitroarginine Methyl Ester; Plasminogen Activator Inhibitor 1; Proteinuria; Sodium, Dietary; Spironolactone | 2003 |
Chronic nitric oxide synthase inhibition exacerbates renal dysfunction in cirrhotic rats.
Topics: Aldosterone; Animals; Blotting, Western; Common Bile Duct; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Kidney Cortex; Kidney Diseases; Kidney Tubules, Proximal; Ligation; Lithium; Liver Cirrhosis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Renal Circulation; Sodium; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Specific Pathogen-Free Organisms | 2004 |
Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.
Topics: Animals; Capillaries; Collagen; Collagen Type I; Creatinine; Endothelin-1; ErbB Receptors; Fibrosis; Gefitinib; Gene Expression Regulation; Genes, Reporter; Glomerulosclerosis, Focal Segmental; Hypertension; Ischemia; Kidney; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Proteinuria; Quinazolines; Rats; Rats, Sprague-Dawley | 2004 |
Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis.
Topics: Albumins; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Western; Cathepsin D; Enalapril; Enzyme Inhibitors; Glomerulonephritis; Immunohistochemistry; Kidney; Kidney Diseases; Losartan; Male; Mycophenolic Acid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Time Factors; Up-Regulation | 2004 |
Does the analysis based on a histological and immunohistochemical grading system in the model of BDL kidney allow the quantification of the degree of injury?
Topics: Animals; Cholestasis, Extrahepatic; Enzyme Inhibitors; Kidney; Kidney Diseases; Male; Models, Animal; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Rats; Rats, Sprague-Dawley | 2004 |
The role of nitric oxide in iron-induced rat renal injury.
Topics: Animals; Arginine; Deferoxamine; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Iron; Iron Chelating Agents; Iron Overload; Kidney; Kidney Diseases; Kidney Function Tests; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Sprague-Dawley; Vitamin E | 2004 |
Simvastatin and L-arginine preserve renal function after ischemia/reperfusion injury.
Topics: Animals; Arginine; Cyclosporine; Drug Therapy, Combination; Glomerular Filtration Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Simvastatin | 2005 |
Effect of molsidomine and L-arginine in cyclosporine nephrotoxicity: role of nitric oxide.
Topics: Administration, Oral; Animals; Arginine; Cyclosporine; Dose-Response Relationship, Drug; Drinking; Drug Therapy, Combination; Enzyme Inhibitors; Immunosuppressive Agents; Injections, Subcutaneous; Kidney Diseases; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Oxidative Stress; Rats; Water Supply | 2005 |
Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Diuretics; Enalapril; Enzyme Inhibitors; Hematocrit; Hemodynamics; Hydrochlorothiazide; Kidney; Kidney Diseases; Kidney Glomerulus; Losartan; Male; NG-Nitroarginine Methyl Ester; Organ Size; Rats; Rats, Inbred SHR; Renal Circulation; Vascular Resistance | 2005 |
Renal damage susceptibility and autoregulation in RF-1 and RF-5 congenic rats.
Topics: Albuminuria; Animals; Animals, Congenic; Blood Pressure; Chimera; Enzyme Inhibitors; Genetic Predisposition to Disease; Glomerulosclerosis, Focal Segmental; Homeostasis; Hypertension; Kidney Diseases; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Proteinuria; Quantitative Trait Loci; Rats; Rats, Inbred ACI; Rats, Inbred Strains; Renal Circulation | 2005 |
Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide.
Topics: Animals; Antineoplastic Agents; Antioxidants; Arginine; Biomarkers; Blood Urea Nitrogen; Body Weight; Cisplatin; Creatinine; Enzyme Inhibitors; Glutathione; Kidney; Kidney Diseases; Kidney Function Tests; Lipid Peroxidation; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Oxidative Stress; Rats | 2005 |
Protective effect of oral L-arginine supplementation on cyclosporine induced nephropathy in rats.
Topics: Animals; Arginine; Atrophy; Cyclosporine; Dietary Supplements; Female; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney Diseases; Kidney Tubules; Necrosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley | 2005 |
Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat.
Topics: Animals; Chronic Disease; Dose-Response Relationship, Drug; Kidney; Kidney Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitrogen Dioxide; omega-N-Methylarginine; Puromycin; Rats; Rats, Inbred WF; Rats, Sprague-Dawley; Time Factors | 2006 |
Role of nitric oxide in resveratrol-induced renal protective effects of ischemic preconditioning.
Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Biomarkers; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Enzyme Inhibitors; Ischemic Preconditioning; Kidney; Kidney Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2005 |
NO and NOS isoforms in the development of apoptosis in renal ischemia/reperfusion.
Topics: Amidines; Animals; Apoptosis; Benzylamines; Caspase 3; Caspases; Immunohistochemistry; Indazoles; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Ornithine; Rats; Rats, Wistar; Reperfusion Injury | 2006 |
Synergistic QTL interactions between Rf-1 and Rf-3 increase renal damage susceptibility in double congenic rats.
Topics: Administration, Oral; Animals; Animals, Congenic; Blood Pressure; Chromosome Mapping; Chromosomes, Mammalian; Enzyme Inhibitors; Follow-Up Studies; Genetic Markers; Genetic Predisposition to Disease; Genome; Homeostasis; Homozygote; Hypertension, Renal; Kidney Diseases; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Proteinuria; Quantitative Trait Loci; Rats; Rats, Inbred ACI; Renal Circulation; Survival Analysis; Time Factors | 2006 |
Renal effects of HMG-CoA reductase inhibition in a rat model of chronic inhibition of nitric oxide synthesis.
Topics: Albuminuria; Analysis of Variance; Animals; Atorvastatin; Blood Pressure; Caveolin 1; Glomerular Filtration Rate; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Diseases; Kidney Glomerulus; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyrroles; Rats; Rats, Wistar; rhoA GTP-Binding Protein; Vascular Endothelial Growth Factor A | 2006 |
Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity.
Topics: Acetylglucosaminidase; Animals; Creatinine; Disease Models, Animal; Enzyme Inhibitors; Gentamicins; Glomerular Filtration Rate; Kidney; Kidney Diseases; Lysine; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley | 2007 |
Sodium nitroprusside and L-arginine attenuates ferric nitrilotriacetate-induced oxidative renal injury in rats.
Topics: Animals; Arginine; Blood Urea Nitrogen; Creatinine; Drug Interactions; Enzyme Inhibitors; Ferric Compounds; Glutathione; Histocytochemistry; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitrilotriacetic Acid; Nitroprusside; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2007 |
Attenuation of reperfusion injury by renal ischemic postconditioning: the role of NO.
Topics: Animals; Apoptosis; Endothelin-1; Gene Expression Regulation; Ischemic Preconditioning; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Reperfusion Injury; RNA, Messenger | 2007 |
Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage.
Topics: Albuminuria; Angiotensin II; Animals; Atherosclerosis; Cells, Cultured; Endothelial Cells; Gene Expression Regulation; Humans; Hypertension; I-kappa B Proteins; Inflammation; Intercellular Adhesion Molecule-1; Kidney Diseases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Cardiovascular; Nephritis; NF-kappa B; NF-KappaB Inhibitor alpha; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Organ Specificity; Receptor, TIE-1; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sodium Chloride, Dietary; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2007 |
Chromosomal mapping of the genetic basis of hypertension and renal disease in FHH rats.
Topics: Albuminuria; Animals; Blood Pressure; Chromosome Mapping; Creatinine; Enzyme Inhibitors; Female; Heart Rate; Hypertension; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Phenotype; Proteinuria; Rats; Rats, Inbred BN; Renin; Sex Characteristics; Species Specificity; X Chromosome; Y Chromosome | 2007 |
Cytoprotective role of nitric oxide associated with Hsp70 expression in neonatal obstructive nephropathy.
Topics: Animals; Animals, Newborn; Apoptosis; Arginine; bcl-2-Associated X Protein; Body Weight; Caspase 3; Cytoprotection; Disease Models, Animal; Female; HSP70 Heat-Shock Proteins; Immunoprecipitation; Kidney; Kidney Diseases; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Organ Size; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Superoxide Dismutase; Ureteral Obstruction | 2008 |
Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Evaluation Studies as Topic; Hypertension, Renal; Kidney Diseases; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prodrugs; Rats; Rats, Wistar; Renin-Angiotensin System; Sodium, Dietary; Tetrazoles | 1994 |
Exogenous nitric oxide prevents endotoxin-induced glomerular thrombosis in rats.
Topics: Animals; Arginine; Blood Pressure; Kidney Diseases; Kidney Glomerulus; Lipopolysaccharides; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; Rats; Rats, Sprague-Dawley; Thrombosis | 1994 |
Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity.
Topics: Animals; Arginine; Blood Pressure; Cyclosporine; Glomerular Filtration Rate; Hemodynamics; Kidney Diseases; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Renal Circulation; Vasoconstriction | 1994 |
Effect of NG-nitro-L-arginine methyl ester on nephrotoxicity induced by gentamicin in rats.
Topics: Animals; Arginine; Blood Pressure; Creatinine; Enzyme Inhibitors; Gentamicins; Kidney; Kidney Diseases; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar | 1995 |
Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade.
Topics: Albuminuria; Animals; Arginine; Diet, Sodium-Restricted; Dose-Response Relationship, Drug; Hemodynamics; Hypertension; Kidney; Kidney Diseases; Male; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Renal Circulation; Renin; Time Factors | 1996 |
Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition.
Topics: Animals; Arginine; Body Weight; Cyclosporine; Diet, Sodium-Restricted; Enzyme Inhibitors; Hemodynamics; Kidney Cortex; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 1996 |
Renal denervation prevents intraglomerular platelet aggregation and glomerular injury induced by chronic inhibition of nitric oxide synthesis.
Topics: Albuminuria; Animals; Arginine; Denervation; Enzyme Inhibitors; Fibrinogen; Histocytochemistry; Kidney; Kidney Diseases; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Aggregation; Rats; Rats, Sprague-Dawley | 1996 |
Improved survival in rats administered NG-nitro L-arginine methyl ester due to converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Enzyme Inhibitors; Isoquinolines; Kidney; Kidney Diseases; Kidney Function Tests; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines | 1996 |
Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Collagen; Enalapril; Enzyme Inhibitors; Female; Fibrosis; Kidney; Kidney Diseases; Kidney Tubules; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Ureteral Obstruction | 1996 |
Difference in susceptibility of developing renal damage in normotensive fawn-hooded (FHL) and August x Copenhagen Irish (ACI) rats after N(omega)-nitro-L-arginine methyl ester induced hypertension.
Topics: Albuminuria; Animals; Disease Susceptibility; Enzyme Inhibitors; Hypertension; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Inbred ACI; Regression Analysis; Species Specificity | 1997 |
Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity.
Topics: Animals; Arginine; Blood Pressure; Cyclosporine; Enzyme Inhibitors; Fibrosis; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vascular Diseases | 1997 |
Brief pharmacological intervention in experimental radiation nephropathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enzyme Inhibitors; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Radiation Injuries, Experimental; Rats; Whole-Body Irradiation | 1998 |
Locally activated renin-angiotensin system associated with TGF-beta1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats.
Topics: Actins; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Enzyme Inhibitors; Fibronectins; Imidazoles; Imidazolidines; Kidney; Kidney Cortex; Kidney Diseases; Male; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; RNA, Messenger; Time Factors; Transforming Growth Factor beta | 2000 |
Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
Topics: Animals; Arginine; Arterioles; Biglycan; Blood Pressure; Blotting, Northern; Chronic Disease; Collagen; Cyclosporine; Enzyme Inhibitors; Extracellular Matrix Proteins; Fibronectins; Fibrosis; Gene Expression; Glomerular Filtration Rate; Hyalin; Immunosuppressive Agents; Kidney Diseases; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plasminogen Activator Inhibitor 1; Proteoglycans; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta | 2000 |
Effects of nitric oxide synthesis inhibition on FK506-induced nephrotoxicity in rats.
Topics: Animals; Enzyme Inhibitors; Immunosuppressive Agents; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Tacrolimus | 2001 |
Radiographic contrast media induced nephropathy: experimental observations and the protective effect of calcium channel blockers.
Topics: Animals; Calcium Channel Blockers; Chromium; Contrast Media; Diatrizoate; Diltiazem; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoprostenol; Indomethacin; Injections, Intraperitoneal; Iohexol; Kidney Diseases; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 2001 |